Biogen's injectable pen for Avonex receives FDA approval

02/28/2012 | Boston Globe (tiered subscription model), The

The FDA approved Biogen Idec's user-friendly injectable pen for delivering Avonex, a multiple sclerosis drug. Biogen also obtained approval for a dosing schedule intended to relieve flu-like symptoms normally associated with Avonex.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN